Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia

Saved in:
Bibliographic Details
Published in:Journal of cardiology 2020-09, Vol.76 (3), p.323-324
Main Authors: Kobayashi, Shigeki, Yoshiga, Yasuhiro, Yano, Masafumi
Format: Article
Language:English
Subjects:
Arrhythmias, Cardiac - drug therapy
Dantrolene
Double-Blind Method
Heart Failure
Humans
Morbidity
Ryanodine Receptor Calcium Release Channel - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63
cites cdi_FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63
container_end_page 324
container_issue 3
container_start_page 323
container_title Journal of cardiology
container_volume 76
creator Kobayashi, Shigeki
Yoshiga, Yasuhiro
Yano, Masafumi
description
doi_str_mv 10.1016/j.jjcc.2020.03.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2392459904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0914508720301246</els_id><sourcerecordid>2392459904</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63</originalsourceid><addsrcrecordid>eNp9kLFu2zAURYmiQeOk_YEOBbd2kfJISqRZZDGCpAlgIIDhzARFPVkUZMsl6QDa-g_9w3xJZDjN2Okt517cdwj5yiBnwORVl3edczkHDjmIHBj7QGZsrmRWKDH_SGagWZGVMFfn5CLGDkCCnstP5FxwAUpAOSP3i0Nqh_A90oD7fvxJ1y3S1bji9OXPX7q2YYPJ7zY0tRjsfqR2Y_0uJtpjam1PbQjtmNqtt5_JWWP7iF_e7iV5urtd39xny8dfDzeLZeYKDSlDIauGcyaqBsW0T0nNoXLAG4cVL6vaaqdKyVWh68aqonTIGDpUlZNMNlJckh-n3n0Yfh8wJrP10WHf2x0Oh2i40LwotYZiQvkJdWGIMWBj9sFvbRgNA3M0aDpzNGiOBg0IMxmcQt_e-g_VFuv3yD9lE3B9AnD68tljMNF53DmsfUCXTD34__W_AjFNgiQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2392459904</pqid></control><display><type>article</type><title>Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia</title><source>ScienceDirect Freedom Collection</source><creator>Kobayashi, Shigeki ; Yoshiga, Yasuhiro ; Yano, Masafumi</creator><creatorcontrib>Kobayashi, Shigeki ; Yoshiga, Yasuhiro ; Yano, Masafumi</creatorcontrib><identifier>ISSN: 0914-5087</identifier><identifier>EISSN: 1876-4738</identifier><identifier>DOI: 10.1016/j.jjcc.2020.03.011</identifier><identifier>PMID: 32307305</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Arrhythmias, Cardiac - drug therapy ; Dantrolene ; Double-Blind Method ; Heart Failure ; Humans ; Morbidity ; Ryanodine Receptor Calcium Release Channel - genetics</subject><ispartof>Journal of cardiology, 2020-09, Vol.76 (3), p.323-324</ispartof><rights>2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63</citedby><cites>FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32307305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kobayashi, Shigeki</creatorcontrib><creatorcontrib>Yoshiga, Yasuhiro</creatorcontrib><creatorcontrib>Yano, Masafumi</creatorcontrib><title>Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia</title><title>Journal of cardiology</title><addtitle>J Cardiol</addtitle><subject>Arrhythmias, Cardiac - drug therapy</subject><subject>Dantrolene</subject><subject>Double-Blind Method</subject><subject>Heart Failure</subject><subject>Humans</subject><subject>Morbidity</subject><subject>Ryanodine Receptor Calcium Release Channel - genetics</subject><issn>0914-5087</issn><issn>1876-4738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kLFu2zAURYmiQeOk_YEOBbd2kfJISqRZZDGCpAlgIIDhzARFPVkUZMsl6QDa-g_9w3xJZDjN2Okt517cdwj5yiBnwORVl3edczkHDjmIHBj7QGZsrmRWKDH_SGagWZGVMFfn5CLGDkCCnstP5FxwAUpAOSP3i0Nqh_A90oD7fvxJ1y3S1bji9OXPX7q2YYPJ7zY0tRjsfqR2Y_0uJtpjam1PbQjtmNqtt5_JWWP7iF_e7iV5urtd39xny8dfDzeLZeYKDSlDIauGcyaqBsW0T0nNoXLAG4cVL6vaaqdKyVWh68aqonTIGDpUlZNMNlJckh-n3n0Yfh8wJrP10WHf2x0Oh2i40LwotYZiQvkJdWGIMWBj9sFvbRgNA3M0aDpzNGiOBg0IMxmcQt_e-g_VFuv3yD9lE3B9AnD68tljMNF53DmsfUCXTD34__W_AjFNgiQ</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Kobayashi, Shigeki</creator><creator>Yoshiga, Yasuhiro</creator><creator>Yano, Masafumi</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200901</creationdate><title>Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia</title><author>Kobayashi, Shigeki ; Yoshiga, Yasuhiro ; Yano, Masafumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Arrhythmias, Cardiac - drug therapy</topic><topic>Dantrolene</topic><topic>Double-Blind Method</topic><topic>Heart Failure</topic><topic>Humans</topic><topic>Morbidity</topic><topic>Ryanodine Receptor Calcium Release Channel - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kobayashi, Shigeki</creatorcontrib><creatorcontrib>Yoshiga, Yasuhiro</creatorcontrib><creatorcontrib>Yano, Masafumi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kobayashi, Shigeki</au><au>Yoshiga, Yasuhiro</au><au>Yano, Masafumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia</atitle><jtitle>Journal of cardiology</jtitle><addtitle>J Cardiol</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>76</volume><issue>3</issue><spage>323</spage><epage>324</epage><pages>323-324</pages><issn>0914-5087</issn><eissn>1876-4738</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32307305</pmid><doi>10.1016/j.jjcc.2020.03.011</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0914-5087
ispartof Journal of cardiology, 2020-09, Vol.76 (3), p.323-324
issn 0914-5087
1876-4738
language eng
recordid cdi_proquest_miscellaneous_2392459904
source ScienceDirect Freedom Collection
subjects Arrhythmias, Cardiac - drug therapy
Dantrolene
Double-Blind Method
Heart Failure
Humans
Morbidity
Ryanodine Receptor Calcium Release Channel - genetics
title Author's reply: The RyR2 – Targeting therapy against lethal arrhythmia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A53%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Author's%20reply:%20The%20RyR2%20%E2%80%93%20Targeting%20therapy%20against%20lethal%20arrhythmia&rft.jtitle=Journal%20of%20cardiology&rft.au=Kobayashi,%20Shigeki&rft.date=2020-09-01&rft.volume=76&rft.issue=3&rft.spage=323&rft.epage=324&rft.pages=323-324&rft.issn=0914-5087&rft.eissn=1876-4738&rft_id=info:doi/10.1016/j.jjcc.2020.03.011&rft_dat=%3Cproquest_cross%3E2392459904%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-e36bf2213bfe309176920bc02fceb25bda9c7562749dfa745ce11ece7bc616f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2392459904&rft_id=info:pmid/32307305&rfr_iscdi=true